Joshua S. Norman

Joshua S. Norman

Auto-generated profile, based on publicly available information

Joshua S. Norman

Department of Internal Medicine, Stanford, California, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2023 in Journal of Hepatology
Verified
Journal Article
Closed access
JNJoshua S. Norman
Joshua S. Norman
PLP. Jonathan Li
P. Jonathan Li
PKPrashant Kotwani
Prashant Kotwani
ASAmy M. Shui
Amy M. Shui
FYFrancis Yao
Francis Yao
NMNeil Mehta MD
Neil Mehta MD

13 July 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
PSPhilip O Scumpia
Philip O Scumpia
GBGiovanni A Botten
Giovanni A Botten
JNJoshua S Norman
Joshua S Norman
KKKindra M Kelly-Scumpia
Kindra M Kelly-Scumpia
RSRoberto Spreafico
Roberto Spreafico
SSStephen T Smale
Stephen T Smale
Successful host defense against pathogens requires innate immune recognition of the correct pathogen associated molecular patterns (PAMPs) by pathogen recognition receptors (PRRs) to trigger the appropriate gene program tailored to the pathogen. While many PRR pathways contribute to the innate immune response to specific pathogens, the relative importance of each pathway for the complete transcriptional program elicited has not been examined in detail. Herein, we used RNA-sequencing with wildtype and mutant macrophages to delineate the innate immune pathways contributing to the early transcriptional response to Staphylococcus aureus, a ubiquitous microorganism that can activate a wide variety of PRRs. Unexpectedly, two PRR pathways—the Toll-like receptor (TLR) and Stimulator of Interferon Gene (STING) pathways—were identified as dominant regulators of approximately 95% of the genes that were potently induced within the first four hours of macrophage infection with live S. aureus. TLR signaling predominantly activated a pro-inflammatory program while STING signaling activated an antiviral/type I interferon response with live but not killed S. aureus. This STING response was largely dependent on the cytosolic DNA sensor cyclic guanosine-adenosine synthase (cGAS). Using a cutaneous infection model, we found that the TLR and STING pathways played opposite roles in host defense to S. aureus. TLR signaling was required for host defense, with its absence reducing interleukin (IL)-1β production and neutrophil recruitment, resulting in increased bacterial growth. In contrast, absence of STING signaling had the opposite effect, enhancing the ability to restrict the infection. These results provide novel insights into the complex interplay of innate immune signaling pathways triggered by S. aureus and uncover opposing roles of TLR and STING in cutaneous host defense to S. aureus. Individual pathogen associated molecular patterns (PAMPs) induce gene expression in immune cells through distinct signaling pathways to protect cells from infection. However, pathogens typically possess many PAMPs, and the precise contribution of each PAMP to the gene expression program elicited by a live pathogen has not been clearly defined. Herein, we used gene expression profiling to examine the full early response of macrophages to Staphylococcus aureus, a major human opportunistic pathogen. Surprisingly, we found that two pathogen-sensing pathways, Toll-like receptor (TLR) and Stimulator of Interferon Signaling Gene (STING) pathways, contribute to the activation of ~95% of the genes induced by S. aureus infection. The remaining genes may be induced by hypoxia pathways. When the bacterium is dead, 98% of the gene induction occurs through TLR signaling, and neither STING nor hypoxia contributes greatly to the response. STING activation requires sensing of S. aureus DNA by the cytosolic DNA sensor, cGAS. During S. aureus skin infection, the TLR and STING pathways compete with each other to induce or suppress host defense, respectively, by counter regulating interleukin 1β production and neutrophil recruitment. A similar approach may allow delineation of the relative contributions of immune pathways in the response to various live pathogens.

30 November 2024 in Gastroenterology
Verified
Journal Article
Closed access
JNJoshua S. Norman
Joshua S. Norman
NMNeil Mehta
Neil Mehta
WKW. Ray Kim
W. Ray Kim
JLJane W. Liang
Jane W. Liang
SBScott W. Biggins
Scott W. Biggins
AKAllison J. Kwong
Allison J. Kwong

12 December 2024 in Liver Transplantation
Verified
Journal Article
Closed access
JNJoshua S. Norman
Joshua S. Norman
PLP. Jonathan Li
P. Jonathan Li
PKPrashant Kotwani
Prashant Kotwani
FYFrancis Y. Yao
Francis Y. Yao
SPSarah Pham
Sarah Pham
NMNeil Mehta MD
Neil Mehta MD
Background: The RETREAT (Risk Estimation of Tumor Recurrence after Transplant) Score is a validated tool to predict post-transplant HCC recurrence risk. AFP bound to Lens culinaris agglutinin (AFP-L3) and des-gamma-carboxyprothrombin (DCP) measured at transplant predict worse post-LT survival and may improve the RETREAT score. Results: Our cohort comprised 284 patients transplanted for HCC who were within or downstaged to Milan, with 23 (8.1%) experiencing HCC recurrence. The modified RETREAT (mRETREAT) score assigns AFP-L3 ≥15% 2 points and DCP ≥ 7.5 ng/mL 3 points. Patients with a modified RETREAT score ≥4 showed a 3-year recurrence-free survival (RFS) of 73.2%, versus 97.8% RFS if <4. In comparison, the original RETREAT score had a 3-year RFS of 80.0% if ≥2 versus 98.0% if <2. mRETREAT demonstrated a superior AUC of 0.86, compared to original RETREAT’s 0.82, and enhanced calibration and accuracy with a lower Brier score (0.04). Conclusion: The integration of AFP-L3 and DCP into the RETREAT score appears to enhance prediction of post-LT HCC recurrence. Given these promising results, further study in a larger multi-center cohort is warranted for empiric derivation and validation of a modified RETREAT score including AFP-L3 and DCP. Export

26 September 2019 in The American Journal of Bioethics
Verified
Journal Article
Closed access
AHAnita Ho
Anita Ho
JNJoshua S. Norman
Joshua S. Norman
(2019). Social Determinants of Mental Health and Physician Aid-in-Dying: The Real Moral Crisis. The American Journal of Bioethics: Vol. 19, No. 10, pp. 52-54.

1 January 2024 in Clinical Liver Disease
Verified
Journal Article
Closed access
AKAllison J. Kwong
Allison J. Kwong
JNJoshua Norman
Joshua Norman
SBScott W. Biggins
Scott W. Biggins